IMODIUM CALMING LIQUID DIN 02291800
Health Canada record
| Active ingredient(s) | LOPERAMIDE HYDROCHLORIDE 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | A07DA03 LOPERAMIDE |
| Original market date | 11-Jul-2007 |
| Current status date | 12-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Kenvue Canada Inc. — licence 3-002621, currently licensed, last inspection rating C (2025-03-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LOPERAMIDE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02256452 | DIARRHEA RELIEF | VITA HEALTH PRODUCTS INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02248994 | DIARRHEA RELIEF | PHARMASCIENCE INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02499517 | DIARRHEA RELIEF FAST DISSOLVE | JUNO OTC INC | Tablet (Orally-Disintegrating) | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02551586 | DIARRHEA RELIEF LIQUID CAPSULES | JUNO OTC INC | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Approved |
| 02552337 | DIARRHEA RELIEF LIQUID GELS | LABORATOIRE RIVA INC. | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02553139 | DIARRHEA RELIEF LIQUID GELS | ANGITA PHARMA INC. | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02451433 | DIARRHEA RELIEF LIQUID GELS | PHARMASCIENCE INC | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Approved |
| 02245185 | IMODIUM COMPLETE | KENVUE CANADA INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG; SIMETHICONE 125 MG | Marketed |
| 02376016 | IMODIUM LIQUI-GELS | KENVUE CANADA INC. | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02230542 | IMODIUM QUICK DISSOLVE | KENVUE CANADA INC. | Tablet (Orally-Disintegrating) | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02544989 | JAMP LOPERAMIDE | JAMP PHARMA CORPORATION | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02377764 | LOPERAMIDE | APOTEX INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Approved |
| 02225182 | LOPERAMIDE-2 | PRO DOC LIMITEE | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02228351 | PMS-LOPERAMIDE - CAPLET 2MG | PHARMASCIENCE INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02016095 | PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML | PHARMASCIENCE INC | Solution | LOPERAMIDE HYDROCHLORIDE 0.2 MG | Marketed |
| 02238211 | RIVA-LOPERAMIDE | LABORATOIRE RIVA INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02132591 | TEVA-LOPERAMIDE | TEVA CANADA LIMITED | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Marketed |
| 02162784 | ALTI-LOPERAMIDE - 2MG CAPLET | ALTIMED PHARMA INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02170272 | ANTI-DIARRHEAL CAPLETS - 2MG | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02212005 | APO-LOPERAMIDE | APOTEX INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Dormant |
| 02219484 | DIAHALT CAPLETS - 2MG | WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02229552 | DIARR-EZE | PHARMASCIENCE INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02415372 | DIARRHEA RELIEF | TEVA CANADA LIMITED | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02453517 | DIARRHEA RELIEF | LABORATOIRE RIVA INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Dormant |
| 02164450 | DIARRHEA RELIEF - CAPLETS 2MG | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02239535 | DOM-LOPERAMIDE CAPLETS 2MG | DOMINION PHARMACAL | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02183862 | IMODIUM - CAPLET 2MG | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 00579343 | IMODIUM CAP 2MG | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Capsule | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 00860743 | IMODIUM CAPLETS 2MG | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02237297 | IMODIUM COMPLETE CHEWABLE TABLETS | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Tablet (Chewable) | LOPERAMIDE HYDROCHLORIDE 2 MG; SIMETHICONE 125 MG | Cancelled Post Market |
| 02228343 | LOPERACAP | BAUSCH HEALTH, CANADA INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Dormant |
| 02238052 | LOPERAMIDE | LABORATOIRES TRIANON INC. | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02244262 | LOPERAMIDE | D.C. LABS LIMITED | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02240415 | LOPERAMIDE HYDROCHLORIDE | VITA HEALTH PRODUCTS INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02298198 | PHL-LOPERAMIDE | PHARMEL INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02233998 | RHOXAL-LOPERAMIDE | RHOXALPHARMA INC | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02257564 | SANDOZ LOPERAMIDE | SANDOZ CANADA INCORPORATED | Tablet | LOPERAMIDE HYDROCHLORIDE 2 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37085 | 2026-03-12 | New Drug Submission (NDS) | Administrative: Change in manufacturer name |
| 29732 | 2022-12-19 | Supplement to a New Drug Submission (SNDS) | Approval of safety labelling update |
| 22274 | 2019-05-31 | Supplement to a New Drug Submission (SNDS) | LABELLING UPDATE TO COMPLY WITH THE PLAIN LANGUAGE LABELLING REGULATIONS |
| 12313 | 2011-05-05 | Supplement to a New Drug Submission (SNDS) | Product name change |
| 8582 | 2007-02-12 | Supplement to a New Drug Submission (SNDS) | NEW DOSAGE FORM |
International API supply for LOPERAMIDE HYDROCHLORIDE
6 valid EDQM Certificates of Suitability from 5 holders. 6 active FDA Drug Master Files.
Request a quote for IMODIUM CALMING LIQUID